Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 28;28(5):2263.
doi: 10.3390/molecules28052263.

Phytochemicals, Antioxidant and Antimicrobial Potentials and LC-MS Analysis of Centaurea parviflora Desf. Extracts

Affiliations

Phytochemicals, Antioxidant and Antimicrobial Potentials and LC-MS Analysis of Centaurea parviflora Desf. Extracts

Fatima Zohra Hechaichi et al. Molecules. .

Abstract

Centaurea parviflora (C. parviflora), belonging to the family Asteraceae, is an Algerian medicinal plant used in folk medicine to treat different diseases related to hyperglycemic and inflammatory disorders, as well as in food. The present study aimed to assess the total phenolic content, in vitro antioxidant and antimicrobial activity and phytochemical profile of the extracts of C. parviflora. The extraction of phenolic compounds from aerial parts was conducted using solvents of increasing polarity starting from methanol, resulting in crude extract (CE), to chloroform extract (CHE), ethyl acetate extract (EAE) and butanol extract (BUE). The total phenolic, flavonoid and flavonol contents of the extracts were determined using the Folin-Ciocalteu and AlCl3 methods, respectively. The antioxidant activity was measured with seven methods: 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, galvinoxyl free-radical-scavenging test, 2,2'-Azino-Bis(3-Ethylbenzothiazoline-6-Sulfonic Acid) (ABTS) assay, cupric reducing antioxidant capacity (CUPRAC), reducing power, Fe+2-phenanthroline reduction assay and superoxide-scavenging test. The disc-diffusion method aimed at testing the sensitivity of bacterial strains toward our extracts. A qualitative analysis with thin-layer chromatography of the methanolic extract was performed. Moreover, HPLC-DAD-MS was used to establish the phytochemical profile of the BUE. The BUE was found to contain high amounts of total phenolics (175.27 ± 2.79 µg GAE/mg E), flavonoids (59.89 ± 0.91 µg QE/mg E) and flavonols (47.30 ± 0.51 µg RE/mg E). Using TLC, different components such as flavonoids and polyphenols were noted. The highest radical-scavenging ability was recorded for the BUE against DPPH (IC50 = 59.38 ± 0.72 µg/mL), galvinoxyl (IC50 = 36.25 ± 0.42 µg/mL), ABTS (IC50 = 49.52 ± 1.54 µg/mL) and superoxide (IC50 = 13.61 ± 0.38 µg/mL). The BUE had the best reducing power according to the CUPRAC (A0.5 = 71.80 ± 1.22 μg/mL), phenanthroline test (A0.5 = 20.29 ± 1.16 μg/mL) and FRAP (A0.5 = 119.17 ± 0.29 μg/mL). The LC-MS analysis of BUE allowed us to identify eight compounds including six phenolic acids and two flavonoids: quinic acid, five chlorogenic acid derivatives, rutin and quercetin 3-o-glucoside. This preliminary investigation revealed that the extracts of C. parviflora have a good biopharmaceutical activity. The BUE possesses an interesting potential for pharmaceutical/nutraceutical applications.

Keywords: Centaurea parviflora; LC-MS; TLC; antimicrobial; antioxidant activity; flavonoids; polyphenols.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Photos of TLC results of methanolic extract of C. parviflora. (A) Toluene/Chloroform/Methanol; (B) Chloroform/Methanol; (C) Ethyl Acetate/Methanol/Water; (D) Methanol/Water; (E) Butanol/Acetic acid/Water.
Figure 2
Figure 2
Chromatogram of the positive ionization of the butanol extract of C. parviflora.
Figure 3
Figure 3
Chromatogram of the negative ionization of the butanol extract of C. parviflora.
Figure 4
Figure 4
Chromatogram of quinic acid (compound 1).
Figure 5
Figure 5
Mass spectrum of quinic acid (compound 1).
Figure 6
Figure 6
Chromatogram of chlorogenic acid (compounds 2, 3, 4 and 5).
Figure 7
Figure 7
Mass spectrum of chlorogenic acid (compounds 2, 3, 4 and 5).
Figure 8
Figure 8
Chromatogram of rutin (compound 6).
Figure 9
Figure 9
Mass spectrum of rutin (compound 6).
Figure 10
Figure 10
Chromatogram of quercetin 3-O-glucoside (compound 7).
Figure 11
Figure 11
Mass spectrum of quercetin 3-O-glucoside (compound 7).
Figure 12
Figure 12
Chromatogram of chlorogenic acid derivative (compound 8).
Figure 13
Figure 13
Mass spectrum of chlorogenic acid derivative (compound 8).
Figure 14
Figure 14
Photographs of the antibacterial activity results according to the agar disk-diffusion method of C. parviflora. 1. Standard (solvent), 2. 20 mg/mL, 3. 30 mg/mL.
Figure 14
Figure 14
Photographs of the antibacterial activity results according to the agar disk-diffusion method of C. parviflora. 1. Standard (solvent), 2. 20 mg/mL, 3. 30 mg/mL.

Similar articles

Cited by

References

    1. Sánchez-Chávez E., Rodríguez A., Castro-Castro A., Angel Pérez- Farrera M., Sosa V. Spatio-temporal evolution of climbing habit in the Dahlia-Hidalgoa group (Coreopsidae, Asteraceae) Mol. Phylogenet. Evol. 2019;135:166–176. doi: 10.1016/j.ympev.2019.03.012. - DOI - PubMed
    1. Lawrence G.H.M. Taxonomy of Vascular Plants. Oxford and IBM Publishing Co.; New Delhi, India: 1973. Rakes Press.
    1. Matsuda H., Morikawa T., Toguchida I., Harima S., Yoshikawa M. Medicinal Flowers. VI. Absolute Stereostructures of Two New Flavanone Glycosides and a Phenylbutanoid Glycoside from the Flowers of Chrysanthemum indicum L.: Their Inhibitory Activities for Rat Lens Aldose Reductase. Chem. Pharm. Bull. 2002;50:972. doi: 10.1248/cpb.50.972. - DOI - PubMed
    1. Da Silva A.C.N., do Nascimento R.M.C., do Rodrigues D.C.N., Ferreira P.M.P., Pessoa C., Lima D.J.B., de Moraes Filho M.O., de Almeida R.M., Ferreira S.R., Fujiwara R.T., et al. In vitro activity evaluation of seven Brazilian Asteraceae against cancer cells and Leishmania amazonensis. S. Afr. J. Bot. 2019;121:267–273. doi: 10.1016/j.sajb.2018.11.008. - DOI
    1. Sarembaud A., Poitevin B. Médicament à usage homéopathique. Ed. Masson; Paris, France: 1996. p. 256.

LinkOut - more resources